The Psychiatric-PGX panel offers personalized treatment plans for neuropsychiatric disorders, including depression, anxiety, bipolar disorder, and schizophrenia. By analyzing genes that influence drug metabolism and response, this test helps healthcare providers tailor psychiatric medications to your unique genetic makeup, enhancing treatment outcomes and minimizing side effects.

This comprehensive genetic test helps in developing personalized treatment strategies, ensuring that psychiatric medications are selected and dosed based on your genetic profile. By understanding your genetic predispositions, healthcare providers can enhance therapeutic efficacy, reduce the risk of adverse drug reactions, and improve overall mental health management.